GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first nine months of 2014 with substantial gains. Consolidated order intake grew 10.1% in constant currencies; Group sales revenue rose 9.6%. Operating profit1) for the Group also climbed 10.7%; its respective margin after nine months was 19.6%. Based on the strong results of the past three quarters, Sartorius confirms its forecast for the full year of 2014, which projects currency-adjusted growth in sales of 8% to 10% and an increase in its EBITDA margin to around 20%.
Help employers find you! Check out all the jobs and post your resume.
